In a groundbreaking study published in the Annals of the American Thoracic Society, researchers have provided fresh insights into the link between early-life exposure...
Garvan Institute and Pharmaxis Collaboration for PXS-5505 - Researchers at the Garvan Institute of Medical Research, in collaboration with Australian pharmaceutical company Pharmaxis, have...
Bronchopulmonary dysplasia (BPD) remains a significant concern for preterm infants born below 32 weeks gestation. This condition poses long-term respiratory and neurodevelopmental challenges, affecting...
Maintaining healthy skin is crucial, especially for those leading active lifestyles and engaging in regular workouts. An effective skincare routine before and after exercising...
In a significant scientific breakthrough on Neurodegenerative Diseases Treatment, researchers at the Weizmann Institute of Science have unveiled a protein's pivotal role in regenerating...
A novel and highly mutated lineage of the COVID-19 virus, identified as BA.2.86, has recently emerged, garnering attention from global health authorities. The U.S....
U.S. health officials have issued a recommendation for infants to receive a recently approved drug to guard against respiratory syncytial virus (RSV), a virus...
Sarepta Therapeutics, a leading biopharmaceutical company, has provided an important update on the potential approval of its groundbreaking gene therapy for Duchenne muscular dystrophy...
